Can ACLU Expect to Win Its BRCA Gene Patenting Case Before it Even Gets to Trial?

According to ACLU Staff Attorney Sandra Park, the organization filed for summary judgment on its case challenging the patentability and constitutionality of Myriad's patents covering BRCA gene mutations because "the case does not turn on factual disputes but on legal questions." One UNC-Chapel Hill law professor following the case closely believes the ACLU is trying to win in the court of public opinion rather than in district court.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.